Tag: CBT > Cannabis Schedule III

Cannabis Rescheduling

DEA Names 7 Anti-Rescheduling Parties for Cannabis Hearing, Zero Pro Parties

Derek C. Julius will be the DEA’s chief administrative law judge to oversee the hearing of a proposed rule to reclassify cannabis as a Schedule III drug.

June 19, 2026

Cannabis Rescheduling

Feds Haven’t Provided ‘Clear Guidance, Feedback’ to Ohio on Cannabis Rescheduling

The state’s Division of Cannabis Control ‘doesn’t have a lot of great answers’ for its dual-licensed operators, the department’s legal counsel says.

June 18, 2026

Cannabis Rescheduling

Anti-Rescheduling Parties Ask Court to Stay Schedule III Cannabis Order

A national drug screening association and a private pharmaceutical cannabinoid development company argue they’ll suffer irreparable harm.

June 11, 2026

Cannabis Rescheduling

5 ‘Aggrieved Persons’ Sue Trump, DOJ Over Cannabis Rescheduling Order

A substance abuse recovery clinic, two doctors, a victims’ advocacy organization and a pharmaceutical company claim the order was unlawful.

June 1, 2026

Cannabis Tax Law

7 House Democrats Demand IRS, Treasury Provide 280E Cannabis Guidance

The U.S. representatives sent a letter urging ‘clear, timely guidance’ for state-licensed medical businesses following the DOJ’s rescheduling order.

May 29, 2026

Cannabis Rescheduling

3 States Challenge Trump DOJ’s Schedule III Cannabis Rule

Nebraska, Indiana and Louisiana filed a petition for review in federal court, arguing that immediately rescheduling medical cannabis violates administrative procedures.

May 27, 2026

Hemp-Derived Cannabinoids

White House’s ‘New Legal Authority’ for Hemp THC Products Leads CBT’s Top Stories in May

The Trump administration’s drug control strategy indicated enforcement of intoxicating hemp products that have largely gone unregulated.

May 27, 2026

Cannabis Rescheduling

Cresco Labs Marks Historic Step Forward With Medical Cannabis Facility DEA Registrations

The registrations are for the company’s dispensary, cultivation and processing operations.

May 27, 2026

SAFE Banking Act

SAFE Banking Act Nowhere to Be Found in Wake of Schedule III Cannabis Order

The new federal posture toward loosening restrictions on cannabis does not appear to have increased congressional appetite for industry banking reform.

May 26, 2026

Cannabis Rescheduling

Cannabis Business Leans on Schedule III Listing, Asks US Tax Court to Recognize 280E Refunds for Prior Years

The IRS can’t dispute that medical cannabis falls outside the meaning of Schedule I or II ‘without contradicting the president, the acting attorney general and HHS,’ the company says.

May 21, 2026

Cannabis Rescheduling

Former Federal Prosecutor, Former IRS Lawyer Warn Cannabis Industry About Jumping on DEA Registration Bandwagon

The takeaway? Consult with experienced lawyers and tax professionals and consider the risks, as the landscape continues to shift.

May 18, 2026

Cannabis Rescheduling

Verano Submits DEA Registration Applications for Schedule III

The multistate operator filed its applications, extended to state-licensed medical cannabis businesses, following the landmark federal rescheduling order.

May 13, 2026